Optipharm.CO.,LTD (KOSDAQ:153710)
South Korea
· Delayed Price · Currency is KRW 4,890.00
-25.00 (-0.51%)
At close: Jun 17, 2025, 3:30 PM KST
Optipharm.CO.,LTD Revenue
Optipharm.CO.,LTD had revenue of 4.92B KRW in the quarter ending March 31, 2025, with 14.37% growth. This brings the company's revenue in the last twelve months to 20.25B, up 13.95% year-over-year. In the year 2024, Optipharm.CO.,LTD had annual revenue of 19.64B with 13.03% growth.
Revenue (ttm)
20.25B
Revenue Growth
+13.95%
P/S Ratio
3.53
Revenue / Employee
n/a
Employees
n/a
Market Cap
71.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19.64B | 2.26B | 13.03% |
| Dec 31, 2023 | 17.37B | 1.36B | 8.52% |
| Dec 31, 2022 | 16.01B | 1.75B | 12.27% |
| Dec 31, 2021 | 14.26B | 1.21B | 9.29% |
| Dec 31, 2020 | 13.05B | -606.93M | -4.45% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| Samsung Biologics | 4,898.69B |
| LG Energy Solution | 25.76T |
| Hyundai Motor Company | 178.98T |
| Hanwha Aerospace | 15.28T |
| Doosan Enerbility | 15.88T |
| Kia Corporation | 109.25T |